Print
David L. Gilliland, Ph.D., R.Ph.
President & Founder of Geodax Imaging
Greensboro, NC
Dr. Gilliland received his Bachelor of Science in Pharmacy degree from Auburn University, and then continued his education at the OU College of Pharmacy by receiving a master’s in Nuclear Pharmacy and a Ph.D. in Pharmaceutical Sciences. Dr. Gilliland served three years as director of the OU Nuclear Pharmacy Service Unit. In 1986, he left OU to open his own nuclear pharmacy in North Carolina with help from a software program designed by Dr. Garo P. Basmadjian, his Ph.D. advisor and director of nuclear pharmacy programs at OU. Gilliland went on to establish 15 more nuclear pharmacies and 2 medical cyclotron facilities. In July 2004, Dr. Gilliland sold his nuclear pharmacies and medical cyclotrons to Cardinal Health.
Currently Dr. Gilliland owns and operates Geodax Imaging. Geodax Imaging was established in 1995 as a medical imaging company focused on developing nuclear medicine imaging and positron emission tomography (PET) imaging.
Currently Dr. Gilliland owns and operates Geodax Imaging. Geodax Imaging was established in 1995 as a medical imaging company focused on developing nuclear medicine imaging and positron emission tomography (PET) imaging.
He and his wife, Sandra, have established the college’s first endowed chair in nuclear pharmacy. The Sandra K. and David L. Gilliland Chair will support research in diagnostic and therapeutic radiopharmaceuticals on the Health Sciences Center campus, the only campus in the country with a full-service nuclear pharmacy on-site.
Dr. Garo Basmadjian, professor and vice chair of pharmaceutical sciences, is the first holder of the Gilliland Chair. This chair is especially meaningful because it was established by a former student.
The endowment will support research in positron emission tomography (PET) imaging, a developing area of nuclear pharmacy that utilizes radiopharmaceuticals that must be produced within close proximity to a cyclotron. These agents will be used for human studies in infectious diseases, oncology, cardiology, neurology, and other fields. Research in this area also will help identify therapeutic agents for nervous system disorders including cognitive and attention disorders, Alzheimer’s disease, Parkinson disease, and nicotine addiction.
About the lecture
"Overcoming Pharmacy’s Challenges"
The profession of Pharmacy in today’s uncertain health care environment seems to be adrift. Some even say lost. How do you, as a young, new and hopefully eager beginning pharmacist find fulfillment in the profession? Where do you go with your “License”? How do you “set a goal”, much less reach it? Is your Pharmacy education and chosen life’s work a “labor of love”, or a “ball and chain”? Can pharmacy provide you with a life-long learning experience? Many people (including me) are questioning pharmacy’s relevance today. Are there answers? YES! And they may surprise you.
Quoted from the 2007-2008 Linda H. and Calvin J. Anthony Distinguished Entrepreneur in Pharmacy Lecture Series Announcement Brochure